Zebra Technologies Corporation anticipates a robust financial outlook with expected revenue growth of 10.8% and earnings growth of 13.6% in the current year, even as its stock faces a 25.3% decline over the past year. Analysts at Morgan Stanley and UBS have increased their price targets, reflecting confidence in the company's future, particularly with a focus on expansion in healthcare, manufacturing, and retail sectors. Currently trading at a 45% discount to its estimated intrinsic value of $420.85 per share, Zebra's performance underscores the potential for recovery amid market challenges.
“Zebra Technologies Corporation · provides · an award-winning portfolio of connected frontline, asset visibility and automation solutions powered by AI · true”